Form 8-K - Current report:
SEC Accession No. 0001213900-25-056415
Filing Date
2025-06-23
Accepted
2025-06-23 07:51:56
Documents
14
Period of Report
2025-06-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246261-8k_cormedix.htm   iXBRL 8-K 23384
2 PRESS RELEASE DATED JUNE 23, 2025 ea024626101ex99-1_cormedix.htm EX-99.1 10647
3 GRAPHIC ex99-1_001.jpg GRAPHIC 16585
  Complete submission text file 0001213900-25-056415.txt   225035

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crmd-20250623.xsd EX-101.SCH 3014
5 XBRL LABEL FILE crmd-20250623_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE crmd-20250623_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0246261-8k_cormedix_htm.xml XML 3673
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 251062982
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)